2020 Q1 Form 10-Q Financial Statement

#000156459020022994 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $35.01M $44.85M $111.3M
YoY Change -21.94% 9.69% 39.68%
Cost Of Revenue $24.22M $30.06M $68.40M
YoY Change -19.42% 16.25% 37.63%
Gross Profit $10.79M $14.79M $42.89M
YoY Change -27.06% -1.61% 43.22%
Gross Profit Margin 30.81% 32.97% 38.53%
Selling, General & Admin $13.37M $11.53M $15.90M
YoY Change 15.97% 16.3% 24.22%
% of Gross Profit 123.98% 77.97% 37.07%
Research & Development $2.427M $1.456M $1.600M
YoY Change 66.69% 9.56% 33.33%
% of Gross Profit 22.5% 9.85% 3.73%
Depreciation & Amortization $1.033M $1.040M $1.080M
YoY Change -0.67% 9.7% -6.9%
% of Gross Profit 9.58% 7.03% 2.52%
Operating Expenses $15.80M $12.99M $17.50M
YoY Change 21.65% 15.5% 25.0%
Operating Profit -$5.013M $1.801M $25.39M
YoY Change -378.35% -52.43% 59.21%
Interest Expense $169.0K $244.0K -$1.000M
YoY Change -30.74% -87.83% -54.55%
% of Operating Profit 13.55% -3.94%
Other Income/Expense, Net -$197.0K $1.662M -$7.300M
YoY Change -111.85% 578.37% 7200.0%
Pretax Income -$5.379M $3.219M $17.20M
YoY Change -267.1% 58.88% 25.55%
Income Tax -$1.800M $164.0K $1.000M
% Of Pretax Income 5.09% 5.81%
Net Earnings -$3.555M $3.055M $24.61M
YoY Change -216.37% 55.71% 72.96%
Net Earnings / Revenue -10.16% 6.81% 22.11%
Basic Earnings Per Share -$0.25 $0.21 $1.73
Diluted Earnings Per Share -$0.25 $0.19 $1.33
COMMON SHARES
Basic Shares Outstanding 14.50M 14.34M 14.24M shares
Diluted Shares Outstanding 14.50M 16.26M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.700M $10.20M $7.100M
YoY Change -14.71% 137.21% 36.54%
Cash & Equivalents $8.733M $10.16M $7.078M
Short-Term Investments
Other Short-Term Assets $5.200M $4.800M $4.500M
YoY Change 8.33% 37.14% 28.57%
Inventory $39.30M $44.48M $49.47M
Prepaid Expenses
Receivables $12.40M $12.46M $52.80M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $65.60M $71.88M $113.8M
YoY Change -8.74% 58.2% 31.18%
LONG-TERM ASSETS
Property, Plant & Equipment $4.002M $5.215M $5.856M
YoY Change -23.26% 31.06% 25.21%
Goodwill $8.515M $0.00
YoY Change
Intangibles $5.740M $997.0K $1.036M
YoY Change 475.73% -26.85% -26.21%
Long-Term Investments
YoY Change
Other Assets $10.30M $900.0K $1.200M
YoY Change 1044.44% -40.0% -14.29%
Total Long-Term Assets $30.14M $10.04M $8.104M
YoY Change 200.07% 46.23% 8.27%
TOTAL ASSETS
Total Short-Term Assets $65.60M $71.88M $113.8M
Total Long-Term Assets $30.14M $10.04M $8.104M
Total Assets $95.73M $81.93M $121.9M
YoY Change 16.86% 56.63% 29.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.50M $13.07M $17.72M
YoY Change -12.01% 33.97% 31.69%
Accrued Expenses $19.40M $16.60M
YoY Change 16.87%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $0.00 $37.40M
YoY Change -100.0% -2.86%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $32.59M $29.65M $73.60M
YoY Change 9.9% 40.83% 8.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $3.021M $4.677M $2.792M
YoY Change -35.41% 102.38% 20.76%
Total Long-Term Liabilities $3.021M $4.677M $2.792M
YoY Change -35.41% -85.55% -90.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.59M $29.65M $73.60M
Total Long-Term Liabilities $3.021M $4.677M $2.792M
Total Liabilities $35.75M $34.52M $84.42M
YoY Change 3.58% -52.54% -27.48%
SHAREHOLDERS EQUITY
Retained Earnings -$117.1M -$128.4M -$131.5M
YoY Change -8.83% -23.88% -22.69%
Common Stock $15.00K $14.00K $14.00K
YoY Change 7.14% 16.67% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.98M $47.41M $37.50M
YoY Change
Total Liabilities & Shareholders Equity $95.73M $81.93M $121.9M
YoY Change 16.86% 56.63% 29.36%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$3.555M $3.055M $24.61M
YoY Change -216.37% 55.71% 72.96%
Depreciation, Depletion And Amortization $1.033M $1.040M $1.080M
YoY Change -0.67% 9.7% -6.9%
Cash From Operating Activities $17.53M $40.96M -$1.110M
YoY Change -57.21% 7.67% -81.09%
INVESTING ACTIVITIES
Capital Expenditures $890.0K $557.0K -$3.030M
YoY Change 59.78% 57.34% 65.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$890.0K -$557.0K -$3.030M
YoY Change 59.78% 57.34% 65.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $101.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.38M -37.46M 5.140M
YoY Change -58.94% -2.66% -58.55%
NET CHANGE
Cash From Operating Activities 17.53M 40.96M -1.110M
Cash From Investing Activities -890.0K -557.0K -3.030M
Cash From Financing Activities -15.38M -37.46M 5.140M
Net Change In Cash 484.0K 3.078M 1.000M
YoY Change -84.28% -487.66% -78.72%
FREE CASH FLOW
Cash From Operating Activities $17.53M $40.96M -$1.110M
Capital Expenditures $890.0K $557.0K -$3.030M
Free Cash Flow $16.64M $40.41M $1.920M
YoY Change -58.83% 7.2% -147.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42868000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4210000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4493000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
317000
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
132000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2814000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40962000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
557000
CY2019Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
85504000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
48000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15384000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-768000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
484000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8249000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7078000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8733000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
161000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
175000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Inventory Net
InventoryNet
49472000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4002000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
65598000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
102547000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5172000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3962000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4057000
CY2020Q1 us-gaap Goodwill
Goodwill
8515000
CY2019Q4 us-gaap Goodwill
Goodwill
8515000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5740000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20786000
CY2020Q1 us-gaap Other Assets
OtherAssets
2563000
CY2020Q1 us-gaap Assets
Assets
95734000
CY2020Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
301000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11503000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44846000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
30059000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
15000
CY2020Q1 us-gaap Liabilities
Liabilities
35751000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177745000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117074000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-703000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
59983000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14506140
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14506140
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35007000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3021000
CY2020Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
9316000
CY2019Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
7439000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
32590000
CY2020Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
140000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3223000
CY2019Q4 us-gaap Liabilities
Liabilities
67964000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176776000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113519000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
116000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
63387000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95734000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131351000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14488152
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14488152
CY2020Q1 us-gaap Gross Profit
GrossProfit
10785000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
24222000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7648000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6881000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2427000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1456000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37496000
CY2019Q1 us-gaap Gross Profit
GrossProfit
14787000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1040000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5723000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4649000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
15798000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
12986000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5013000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1801000
CY2020Q1 us-gaap Interest Expense
InterestExpense
169000
CY2019Q1 us-gaap Interest Expense
InterestExpense
244000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-197000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1662000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5379000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3219000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1824000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
164000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3555000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
3055000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14495000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14336000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14495000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16260000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-819000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-819000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
165000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4374000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3220000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1033000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
222000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
522000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1891000
CY2020Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
2553000
CY2019Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
2532000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
439000
CY2019Q1 us-gaap Inventory Write Down
InventoryWriteDown
783000
CY2019Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
1601000
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
21000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34681000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5981000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11192000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1091000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-132000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5483000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17526000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
890000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-890000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47408000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-557000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
48426000
CY2019Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
48119000
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
63780000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
101000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37463000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3078000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10156000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
268000
CY2019Q1 hear Reclassification Financial Instrument Obligation
ReclassificationFinancialInstrumentObligation
6248000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
63387000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
48000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59983000
CY2019Q1 hear Adjustments To Additional Paid In Capital Reclassification Of Financial Instrument Obligation
AdjustmentsToAdditionalPaidInCapitalReclassificationOfFinancialInstrumentObligation
6248000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
101000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
522000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of estimates<font style="font-style:normal;">: The preparation of accompanying unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates. The novel coronavirus (&#8220;COVID-19&#8221;) pandemic has disrupted worldwide economic markets and the extent to which COVID-19 impacts the Company&#8217;s business, results of operations and financial condition will depend on future developments, which are highly uncertain and difficult to predict. As of March 31, 2020, our liquidity and operations have not been significantly impacted. However, the Company will continue to monitor and assess the impact of the pandemic.</font></p>
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3880000
CY2019Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
12700000
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
1600000
CY2019Q4 hear Potential Earn Outs Payments
PotentialEarnOutsPayments
3400000
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
500000
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1502000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1288000
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
37789000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
44423000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22607000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21540000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18605000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17578000
CY2020Q1 hear Accrued Customer Fees
AccruedCustomerFees
2787000
CY2019Q4 hear Accrued Customer Fees
AccruedCustomerFees
3147000
CY2020Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2436000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4575000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3674000
CY2020Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2149000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3695000
CY2020Q1 hear Foreign Tax Liability Current
ForeignTaxLiabilityCurrent
1340000
CY2019Q4 hear Foreign Tax Liability Current
ForeignTaxLiabilityCurrent
2504000
CY2020Q1 hear Accrued Expenses Current
AccruedExpensesCurrent
7499000
CY2019Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
9522000
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10103000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4362000
CY2020Q1 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1282000
CY2020Q1 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1118000
CY2020Q1 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
165000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10381000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4370000
CY2019Q4 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1004000
CY2019Q4 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
876000
CY2019Q4 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
128000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
708000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
901000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
866000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
837000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
813000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1780000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5905000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.339
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2020Q1 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
2200000
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1777000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
49350
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
26190
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3000
CY2020Q1 hear Forfeited Expired Shares Added Back
ForfeitedExpiredSharesAddedBack
4000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1755000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2142925
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5707
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2160378
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2111618
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1130521
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.83
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.55
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.19
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.61
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.75
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.76
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.50
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M17D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M1D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M17D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M9D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6545982
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2755627
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2708414
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1569200
CY2020Q1 hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11000000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.014
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.501
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.513
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.69
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000
CY2020Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-3555000
CY2019Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1454000
CY2019Q1 hear Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Awards
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedStockAwards
55000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1053000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
816000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3103000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
346000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
743000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
668000
CY2020Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
146000
CY2019Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
243000
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
177000
CY2019Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
207000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
712000
CY2019Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
704000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1577000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
540000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1079000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1619000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
491000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
575000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
220000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
97000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
97000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
275000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1755000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
136000

Files In Submission

Name View Source Status
0001564590-20-022994-index-headers.html Edgar Link pending
0001564590-20-022994-index.html Edgar Link pending
0001564590-20-022994.txt Edgar Link pending
0001564590-20-022994-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g1t5rb3adfix000001.jpg Edgar Link pending
hear-10q_20200331.htm Edgar Link pending
hear-20200331.xml Edgar Link completed
hear-20200331.xsd Edgar Link pending
hear-20200331_cal.xml Edgar Link unprocessable
hear-20200331_def.xml Edgar Link unprocessable
hear-20200331_lab.xml Edgar Link unprocessable
hear-20200331_pre.xml Edgar Link unprocessable
hear-ex311_6.htm Edgar Link pending
hear-ex312_8.htm Edgar Link pending
hear-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending